XML 43 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Balance Sheets (USD $)
In Thousands, unless otherwise specified
Sep. 30, 2013
Dec. 31, 2012
Current assets:    
Cash and cash equivalents $ 235,015 $ 201,989
Marketable securities 331,300 235,592
Accounts receivable, net of reserves of $3,584 and $3,807 at September 30, 2013 and December 31, 2012, respectively 256,453 218,777
Prepaid expenses and other current assets 67,452 51,604
Deferred income tax assets 20,422 20,422
Total current assets 910,642 728,384
Property and equipment, net 424,605 345,091
Marketable securities 620,204 657,659
Goodwill 751,271 723,701 [1]
Acquired intangible assets, net 79,803 84,554
Deferred income tax assets 20,672 21,427
Other assets 77,928 39,811
Total assets 2,885,125 2,600,627
Current liabilities:    
Accounts payable 49,073 43,291
Accrued expenses 171,527 133,087
Deferred revenue 37,025 26,291
Other current liabilities 27,799 275
Total current liabilities 285,424 202,944
Deferred revenue 2,643 2,565
Other liabilities 53,928 49,364
Total liabilities 341,995 254,873
Commitments and contingencies      
Stockholders’ equity:    
Preferred stock, $0.01 par value; 5,000,000 shares authorized; 700,000 shares designated as Series A Junior Participating Preferred Stock; no shares issued or outstanding 0 0
Common stock, $0.01 par value; 700,000,000 shares authorized; 203,958,959 shares issued and 178,707,441 shares outstanding at September 30, 2013 and 200,199,536 shares issued and 177,782,814 shares outstanding at December 31, 2012 2,059 2,015
Additional paid-in capital 5,295,939 5,195,543
Accumulated other comprehensive loss (5,434) (1,640)
Treasury stock, at cost, 25,251,518 shares at September 30, 2013 and 22,416,722 shares at December 31, 2012 (736,870) (624,462)
Accumulated deficit (2,012,564) (2,225,702)
Total stockholders’ equity 2,543,130 2,345,754
Total liabilities and stockholders’ equity $ 2,885,125 $ 2,600,627
[1] Balance as of January 1, 2013 has been revised to reflect purchase accounting measurement period adjustments (Note 6).